77317-53-4

Basic information

• Product Name: 1-bromo-2-methyl-4-phenoxybenzene
• Synonyms: 1-bromo-2-methyl-4-phenoxybenzene
• CAS NO: 77317-53-4
• Molecular Weight: 263.134
• Mol File: 77317-53-4.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 1-bromo-2-methyl-4-phenoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-bromo-2-methyl-4-phenoxybenzene(77317-53-4)
• EPA Substance Registry System: 1-bromo-2-methyl-4-phenoxybenzene(77317-53-4)

Safety Data

• Hazardous Substances Data: 77317-53-4(Hazardous Substances Data)

Usage

Chemical Category

Aromatic compounds

Chemical Structure

Benzene ring with a methyl group and a bromine atom attached, and a phenoxy group attached to the benzene ring

Usage

a. Intermediate or starting material in chemical synthesis reactions
b. Building block in the production of pharmaceuticals, agrochemicals, and specialty chemicals

Toxicity

Mild to moderate
a. Causes irritation to the skin
b. Causes irritation to the eyes
c. Causes irritation to the respiratory tract

Handling and Disposal

Should be handled and disposed of with care due to its toxicity

Upstream product

• 452-63-1 2-Bromo-5-fluorotoluene 
• 108-95-2 phenol 
• 108-39-4 3-methyl-phenol 
• 112880-83-8 5-phenoxy-2-nitrotoluene 
• 14472-14-1 4-bromo-3-methylphenol 
• 98-80-6 phenylboronic acid 
• 13024-16-3 2-methyl-4-phenoxy-phenylamine 
• 591-50-4 iodobenzene 
• 106-31-0 butanoic acid anhydride 
• 3586-14-9 3-phenoxytoluene 
• 107-92-6 butyric acid 
• 802294-64-0 propionic acid 
• 123-62-6 propionic acid anhydride 
• 64-19-7 acetic acid 

Downstream Products

• 77317-54-5 4-phenoxy-2-bromomethylphenyl bromide 
• 262444-30-4 4,4,5,5-tetramethyl-2-(2-methyl-4-phenoxyphenyl)-1,3,2-dioxaborolane 

Relevant articles and documents

DISUBSTITUTED DL ARYLOXYBENZOH ETERODI AZOLE COMPOUNDS

A disubstituted diaryloxybenzoheterodiazole compound having general formula (I): wherein: R1, R2 and R3, which are the same as or different from each other, represent a hydrogen atom; or represent a halogen atom such as, for example, chlorine, bromine, fluorine, iodine, preferably fluorine; or are selected from optionally halogenated linear or branched C1-C12, preferably C1-C8, alkyl groups, optionally substituted phenoxy groups, provided that at least one of R1, R2 and R3 is an optionally substituted phenoxy group and, if R3 is an optionally substituted phenoxy group, at least one of R1, R2 is different from hydrogen; R4, which are the same as or different from each other, represent a hydrogen atom; or are selected from -COOR groups wherein R is selected from linear or branched C1-C8, preferably C1-C4, alkyl groups. This disubstituted diaryloxybenzoheterodiazole compound having general formula (I) may advantageously be used as a spectrum converter in luminescent solar concentrators ("Luminescent Solar Concentrators" - LSCs) which, in turn, are capable of improving the performance of photovoltaic devices (or solar devices) selected, for example, from photovoltaic cells (or solar cells), photovoltaic modules (or solar modules), on either a rigid or flexible support.

TYROSINE KINASE INHIBITORS

The present disclosure provides compounds of formula (I) that are tyrosine kinase inhibitors, in particular Bruton tyrosine kinase ("BTK") inhibitors, and are therefore useful for the treatment of diseases treatable by inhibition of BTK such as cancer, au

SUBSTITUTED IMIDAZOPYR- AND IMIDAZOTRI-AZINES

Fused pyridine-based bicyclic compounds having the structure of Formula I, as defined herein, pharmaceutically acceptable salts thereof, preparation, compositions, and disease treatment therewith. This abstract does not define or limit the invention.